1-1 of 1
Carrillo Munoz Silvia, RN
Close
Sort by
Journal Articles

Imatinib (IMA) Low Dose Reduction Program (LDR) in Chronic Myeloid Leukemia Ph+ (CML Ph+) in a Single Reference Institution in Mexico City. Ongoing Preliminary Results

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Carrillo Munoz Silvia, RN
Journal: Blood
Blood (2019) 134 (Supplement_1): 5921.
https://doi.org/10.1182/blood-2019-130873
Published: 2019